Dear All, First, Alan Carr’s Sep 2019 Antibiotic and Antifungal Update (link) is, as usual, required reading (see also this prior blog). Key highlights: He provides an updated by-month sales report from Jan 2016 through Jul 2019 of all products approved since 2009. Sadly, it remains the case that only 4 drugs have sold more than $100m in the

Dear All, In a marvelous series of tweets, Seema Verma (current Administrator of the US Centers for Medicare and Medicaid Services) today said the following (emphasis is mine): Not-so-fun fact of the day: Most classes of antibiotics prescribed to #Medicare beneficiaries were discovered long ago- before they were even born. #FactFriday #DYK Over time, pathogens have

Dear All: Rick Bright, Director of BARDA, posted an outstanding commentary (link) in Forbes on 10 May 2019 on the Achaogen story (for more background, see my prior Scary/Scarier/Scariest blogs #1 and #2). Here are three excerpts from his commentary: “Since 2010, the Biomedical Advanced Research and Development Authority (BARDA) has been a leader in the fight against

Dear All: I hope your summer is going well! Below, three items of interest. See as well several updates to the future meetings list.  First,Rep. McCarthy recently introduced the FORWARD (Finding Orphan-disease Remedies with Antifungal Research & Development) Act to the United States House. Seeking to support “endemic orphan fungal disease research, incentivize Valley Fever vaccine development, discover